£1.05m
+15%vs Sept 2024Active07914851Private limited companyWoking
DESITIN PHARMA LIMITED
Significant control: Desitin Arzneimittel Gmbh (75–100%), Jonas Nikolaus Rommig (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Desitin Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Desitin Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
DESITIN PHARMA LIMITED is an active private limited company (company number 07914851) incorporated on 18 January 2012, registered in Woking. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 30 September 2025, showing net assets of £1.05m and cash of £1.03m, with 8 employees on average. Net assets rose 15% on the prior period (£913k).
Peer position · net assets
By net assets it sits in the top quarter of 50 comparable companies in Surrey (median £3,179, upper quartile £541k).
02
Ownership and control
- Desitin Arzneimittel Gmbh
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Jonas Nikolaus Rommig
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 18 January 201214 yrs ago
- Next accounts due
- 30 June 2027in 248 days
- Confirmation statement due
- 1 February 2027in 99 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£1.03m
+4%vs Sept 2024Not reported
8
−11%vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | £1.05m | £1.03m | £279k | £262k | — | — | 8 |
| 30 September 2024 | £913k | £994k | £273k | £357k | — | — | 9 |
Current ratio5.01Current assets ÷ creditors within one year
Cash per employee£129kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,052,942 at 30 September 2025
- Net assets up 10% or more on the prior period+15.4% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.01
- Cash at bank of £50,000 or moreCash £1,034,515
- Incorporated five or more years agoIncorporated 18 January 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 248 days
- Confirmation statement duein 99 days
- Accounts period endNet assets £1.05m · small accounts
- Accounts period endNet assets £913k · small accounts
- Incorporated
08
Similar companies in Surrey
- SCOPE OPHTHALMICS LIMITEDCrawley · inc. Dec 2011
- PENLAN PHARMACEUTICALS LIMITEDLiphook · inc. Sept 2011
- APPIA HEALTHCARE LIMITEDGuildford · inc. Sept 2011
- PARASURE LIMITEDHorsham · inc. Jul 2012
- BRANCASTER PHARMA LIMITEDLingfield · inc. Aug 2012
- MCALL CONSULTING LTDHorley · inc. May 2011
All companies incorporated on 18 January 2012 · in Jan 2012.
09
Reminders for DESITIN PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.